Cargando…

Skin‐resident memory T cells as a potential new therapeutic target in vitiligo and melanoma

Tissue‐resident memory T (T(RM)) cells are abundant in the memory T cell pool and remain resident in peripheral tissues, such as the skin, where they act as alarm sensors or cytotoxic killers. T(RM) cells persist long after the pathogen is eliminated and can respond rapidly upon reinfection with the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Willemsen, Marcella, Linkutė, Rugile, Luiten, Rosalie M., Matos, Tiago R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851629/ https://www.ncbi.nlm.nih.gov/pubmed/31230406 http://dx.doi.org/10.1111/pcmr.12803

Ejemplares similares

Targeting the PD-1/PD-L1 Axis in Human Vitiligo
por: Willemsen, Marcella, et al.
Publicado: (2020)

Mechanism of action of 4‐substituted phenols to induce vitiligo and antimelanoma immunity
por: Kammeyer, Arthur, et al.
Publicado: (2019)

Immunity against Non-Melanoma Skin Cancer and the Effect of Immunosuppressive Medication on Non-Melanoma Skin Cancer Risk in Solid Organ Transplant Recipients
por: Bakker, Dixie, et al.
Publicado: (2023)

Is targeting circulating T blood cells a therapeutic option for vitiligo?
por: Matos, T.R.
Publicado: (2020)

Discovery of resident memory T cells in inflammatory vitiligo: A case report
por: Xu, YanLi, et al.
Publicado: (2022)

Vitiligo Skin Biomarkers Associated With Favorable Therapeutic Response
por: Yang, Qianli, et al.
Publicado: (2021)

Advances in vitiligo: Update on therapeutic targets
por: Feng, Yifei, et al.
Publicado: (2022)

Improvement of Opal Multiplex Immunofluorescence Workflow for Human Tissue Sections
por: Willemsen, Marcella, et al.
Publicado: (2021)

Melanoma and Vitiligo: In Good Company
por: Failla, Cristina Maria, et al.
Publicado: (2019)

Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
por: Chang, Wei-Ling, et al.
Publicado: (2021)

Tumor-infiltrating T-cells: important players in clinical outcome of advanced melanoma patients
por: Tjin, Esther P M, et al.
Publicado: (2014)

063 Autoimmunity and disease outcomes of COVID-19, lessons from vitiligo patients
por: Post, N., et al.
Publicado: (2022)

Progressive vitiligo induced by recurrent melanoma
por: Nakai, Yasuo, et al.
Publicado: (2022)

New Perspectives on the Role of Vitiligo in Immune Responses to Melanoma
por: Byrne, Katelyn T., et al.
Publicado: (2011)

Patients’ perspective on current treatments and demand for novel treatments in vitiligo
por: Narayan, V.S., et al.
Publicado: (2020)

The Role of MicroRNAs in Vitiligo: Regulators and Therapeutic Targets
por: Li, Lili
Publicado: (2020)

Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets
por: Dey-Rao, Rama, et al.
Publicado: (2017)

Vitiligo Associated with Melanoma in a Malagasy Woman
por: Ranaivo, I. M., et al.
Publicado: (2019)

A secondary role for hypoxia and HIF1 in the regulation of (IFNγ-induced) PD-L1 expression in melanoma
por: van Duijn, Anneloes, et al.
Publicado: (2021)

Ultraviolet photography in vitiligo: image quality, validity and reliability
por: Uitentuis, S.E., et al.
Publicado: (2020)

Pathophysiology of Skin Resident Memory T Cells
por: Tokura, Yoshiki, et al.
Publicado: (2021)

Integrated analysis to reveal potential therapeutic targets and prognostic biomarkers of skin cutaneous melanoma
por: Zhou, Xuezhi, et al.
Publicado: (2022)

Functional Heterogeneity and Therapeutic Targeting of Tissue-Resident Memory T Cells
por: van der Gracht, Esmé T. I., et al.
Publicado: (2021)

T‐cell responses against 4‐tert‐butylphenol‐exposed pigmented cells in a patient with occupational vitiligo
por: Vrijman, C., et al.
Publicado: (2019)

Biomarkers for Response of Melanoma Patients to Immune Checkpoint Inhibitors: A Systematic Review
por: Jessurun, Charissa A. C., et al.
Publicado: (2017)

Immunity to melanin and to tyrosinase in melanoma patients, and in people with vitiligo
por: Đorđić, Marija, et al.
Publicado: (2012)

Amelanotic Acral Melanoma Associated with KIT Mutation and Vitiligo
por: Kim, Young Jee, et al.
Publicado: (2015)

Resident Memory T Cells in Autoimmune Skin Diseases
por: Ryan, Grace E., et al.
Publicado: (2021)

Vitiligo and the Role of Newer Therapeutic Modalities
por: Nimkar, Prathmesh, et al.
Publicado: (2022)

Vaccination-induced skin-resident memory CD8(+) T cells mediate strong protection against cutaneous melanoma
por: Gálvez-Cancino, Felipe, et al.
Publicado: (2018)

Donor to recipient ratios in the surgical treatment of vitiligo and piebaldism: a systematic review
por: Narayan, V.S., et al.
Publicado: (2021)

Regional vitiligo induced by imiquimod treatment for in-transit melanoma metastases
por: Tkachenko, Elizabeth, et al.
Publicado: (2019)

Networks of CD8(+) T Cell Response Activation in Melanoma and Vitiligo
por: Fukuda, Keitaro
Publicado: (2022)

High Expression of TIMELESS Predicts Poor Prognosis: A Potential Therapeutic Target for Skin Cutaneous Melanoma
por: Zhao, Shixin, et al.
Publicado: (2022)

Split Thickness Skin Grafting in Patients with Stable Vitiligo
por: Sameem, Farah, et al.
Publicado: (2011)

Beyond skin white spots: Vitiligo and associated comorbidities
por: Hu, Zhonghui, et al.
Publicado: (2023)

Effective Melanoma Immunotherapy in Mice by the Skin-Depigmenting Agent Monobenzone and the Adjuvants Imiquimod and CpG
por: van den Boorn, Jasper G., et al.
Publicado: (2010)

Biomarkers, measured during therapy, for response of melanoma patients to immune checkpoint inhibitors: a systematic review
por: Ouwerkerk, Wouter, et al.
Publicado: (2019)

Plant-Derived Compounds as Promising Therapeutics for Vitiligo
por: Pang, Yaobin, et al.
Publicado: (2021)

Onset of vitiligo following targeted therapy for BRAF(V600E)-mutated melanoma: case report
por: Brugnara, Sonia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lol5rs6u3fn70a812mgctej2ro